Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


one a day
Sep 4, 2001

Hi again, haveing told you that I take abacavir, 3tc, and sustivia- twice daily, can any of these be taken once daily? Again, thanks,

Michael

Response from Dr. Boyle

Yes, Sustiva/Stocrin (efavirenz) is FDA approved as a once daily medication. There is a lot of evidence that Epivir (lamivudine) is also suitable for once daily administration. In fact, Glaxo is in the process of filing with the FDA for approval of Epivir once daily. There is less evidence for Ziagen (abacavir) but there is also some evidence that it has a long intracellular half-life and that it may be effective as once daily therapy. At present, I think the evidence pretty clearly supports Epivir once a day but I still have some reluctance about abacavir pending the presentation of further data.



Previous
problems with sustiva
Next
Side Effects...

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement